Tenax Therapeutics Inc

TENX

Add to Watchlist

14.520USD

+0.820+5.99%

Close 07-31 16:00（ET）Quotes delayed by 15 min

463.91MMarket Cap

LossP/E TTM

Tenax Therapeutics Inc

14.520

+0.820+5.99%

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Overview

Financials

Discussions

Analysis

Company

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Tenax Therapeutics Inc's Company Valuation

Currency: USD Updated: 2026-07-31

Previous score

7.41

Change

1.38

The current valuation score of Tenax Therapeutics Inc is 8.79, ranking 57 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -9.76, which is -139.99% below the recent high of 3.90 and -152.06% above the recent low of -24.59.

P/E

Relevant data have not been disclosed by the company yet.

P/B

Relevant data have not been disclosed by the company yet.

P/CF

Relevant data have not been disclosed by the company yet.